Global Seasonal Influenza Vaccines Market Insights, Forecast to 2029

Global Seasonal Influenza Vaccines Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Seasonal Influenza Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Seasonal Influenza Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Type A (H1N1)
1.2.3 Type A (H3N2)
1.2.4 Type B
1.3 Market by Application
1.3.1 Global Seasonal Influenza Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Pediatrics
1.3.3 Adolescence
1.3.4 Adults
1.3.5 Elderly
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Seasonal Influenza Vaccines Sales Estimates and Forecasts 2018-2029
2.2 Global Seasonal Influenza Vaccines Revenue by Region
2.2.1 Global Seasonal Influenza Vaccines Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Seasonal Influenza Vaccines Revenue by Region (2018-2023)
2.2.3 Global Seasonal Influenza Vaccines Revenue by Region (2024-2029)
2.2.4 Global Seasonal Influenza Vaccines Revenue Market Share by Region (2018-2029)
2.3 Global Seasonal Influenza Vaccines Sales Estimates and Forecasts 2018-2029
2.4 Global Seasonal Influenza Vaccines Sales by Region
2.4.1 Global Seasonal Influenza Vaccines Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Seasonal Influenza Vaccines Sales by Region (2018-2023)
2.4.3 Global Seasonal Influenza Vaccines Sales by Region (2024-2029)
2.4.4 Global Seasonal Influenza Vaccines Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Seasonal Influenza Vaccines Sales by Manufacturers
3.1.1 Global Seasonal Influenza Vaccines Sales by Manufacturers (2018-2023)
3.1.2 Global Seasonal Influenza Vaccines Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Seasonal Influenza Vaccines in 2022
3.2 Global Seasonal Influenza Vaccines Revenue by Manufacturers
3.2.1 Global Seasonal Influenza Vaccines Revenue by Manufacturers (2018-2023)
3.2.2 Global Seasonal Influenza Vaccines Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Seasonal Influenza Vaccines Revenue in 2022
3.3 Global Key Players of Seasonal Influenza Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Seasonal Influenza Vaccines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Seasonal Influenza Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Seasonal Influenza Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Seasonal Influenza Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of Seasonal Influenza Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Seasonal Influenza Vaccines Sales by Type
4.1.1 Global Seasonal Influenza Vaccines Historical Sales by Type (2018-2023)
4.1.2 Global Seasonal Influenza Vaccines Forecasted Sales by Type (2024-2029)
4.1.3 Global Seasonal Influenza Vaccines Sales Market Share by Type (2018-2029)
4.2 Global Seasonal Influenza Vaccines Revenue by Type
4.2.1 Global Seasonal Influenza Vaccines Historical Revenue by Type (2018-2023)
4.2.2 Global Seasonal Influenza Vaccines Forecasted Revenue by Type (2024-2029)
4.2.3 Global Seasonal Influenza Vaccines Revenue Market Share by Type (2018-2029)
4.3 Global Seasonal Influenza Vaccines Price by Type
4.3.1 Global Seasonal Influenza Vaccines Price by Type (2018-2023)
4.3.2 Global Seasonal Influenza Vaccines Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Seasonal Influenza Vaccines Sales by Application
5.1.1 Global Seasonal Influenza Vaccines Historical Sales by Application (2018-2023)
5.1.2 Global Seasonal Influenza Vaccines Forecasted Sales by Application (2024-2029)
5.1.3 Global Seasonal Influenza Vaccines Sales Market Share by Application (2018-2029)
5.2 Global Seasonal Influenza Vaccines Revenue by Application
5.2.1 Global Seasonal Influenza Vaccines Historical Revenue by Application (2018-2023)
5.2.2 Global Seasonal Influenza Vaccines Forecasted Revenue by Application (2024-2029)
5.2.3 Global Seasonal Influenza Vaccines Revenue Market Share by Application (2018-2029)
5.3 Global Seasonal Influenza Vaccines Price by Application
5.3.1 Global Seasonal Influenza Vaccines Price by Application (2018-2023)
5.3.2 Global Seasonal Influenza Vaccines Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Seasonal Influenza Vaccines Market Size by Type
6.1.1 US & Canada Seasonal Influenza Vaccines Sales by Type (2018-2029)
6.1.2 US & Canada Seasonal Influenza Vaccines Revenue by Type (2018-2029)
6.2 US & Canada Seasonal Influenza Vaccines Market Size by Application
6.2.1 US & Canada Seasonal Influenza Vaccines Sales by Application (2018-2029)
6.2.2 US & Canada Seasonal Influenza Vaccines Revenue by Application (2018-2029)
6.3 US & Canada Seasonal Influenza Vaccines Market Size by Country
6.3.1 US & Canada Seasonal Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Seasonal Influenza Vaccines Sales by Country (2018-2029)
6.3.3 US & Canada Seasonal Influenza Vaccines Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Seasonal Influenza Vaccines Market Size by Type
7.1.1 Europe Seasonal Influenza Vaccines Sales by Type (2018-2029)
7.1.2 Europe Seasonal Influenza Vaccines Revenue by Type (2018-2029)
7.2 Europe Seasonal Influenza Vaccines Market Size by Application
7.2.1 Europe Seasonal Influenza Vaccines Sales by Application (2018-2029)
7.2.2 Europe Seasonal Influenza Vaccines Revenue by Application (2018-2029)
7.3 Europe Seasonal Influenza Vaccines Market Size by Country
7.3.1 Europe Seasonal Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Seasonal Influenza Vaccines Sales by Country (2018-2029)
7.3.3 Europe Seasonal Influenza Vaccines Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Seasonal Influenza Vaccines Market Size
8.1.1 China Seasonal Influenza Vaccines Sales (2018-2029)
8.1.2 China Seasonal Influenza Vaccines Revenue (2018-2029)
8.2 China Seasonal Influenza Vaccines Market Size by Application
8.2.1 China Seasonal Influenza Vaccines Sales by Application (2018-2029)
8.2.2 China Seasonal Influenza Vaccines Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Seasonal Influenza Vaccines Market Size by Type
9.1.1 Asia Seasonal Influenza Vaccines Sales by Type (2018-2029)
9.1.2 Asia Seasonal Influenza Vaccines Revenue by Type (2018-2029)
9.2 Asia Seasonal Influenza Vaccines Market Size by Application
9.2.1 Asia Seasonal Influenza Vaccines Sales by Application (2018-2029)
9.2.2 Asia Seasonal Influenza Vaccines Revenue by Application (2018-2029)
9.3 Asia Seasonal Influenza Vaccines Sales by Region
9.3.1 Asia Seasonal Influenza Vaccines Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Seasonal Influenza Vaccines Revenue by Region (2018-2029)
9.3.3 Asia Seasonal Influenza Vaccines Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Seasonal Influenza Vaccines Market Size by Type
10.1.1 Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Seasonal Influenza Vaccines Market Size by Application
10.2.1 Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales by Country
10.3.1 Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GlaxoSmithKline plc
11.1.1 GlaxoSmithKline plc Company Information
11.1.2 GlaxoSmithKline plc Overview
11.1.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline plc Recent Developments
11.2 Sinovac Biotech Ltd
11.2.1 Sinovac Biotech Ltd Company Information
11.2.2 Sinovac Biotech Ltd Overview
11.2.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sinovac Biotech Ltd Recent Developments
11.3 Changsheng Bio-Technology
11.3.1 Changsheng Bio-Technology Company Information
11.3.2 Changsheng Bio-Technology Overview
11.3.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Changsheng Bio-Technology Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Changsheng Bio-Technology Recent Developments
11.4 Ccbio SA
11.4.1 Ccbio SA Company Information
11.4.2 Ccbio SA Overview
11.4.3 Ccbio SA Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Ccbio SA Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Ccbio SA Recent Developments
11.5 Aleph Biomedical
11.5.1 Aleph Biomedical Company Information
11.5.2 Aleph Biomedical Overview
11.5.3 Aleph Biomedical Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Aleph Biomedical Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Aleph Biomedical Recent Developments
11.6 Sanofi
11.6.1 Sanofi Company Information
11.6.2 Sanofi Overview
11.6.3 Sanofi Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Sanofi Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sanofi Recent Developments
11.7 Jiangsu Simcere Vaxtec Bio-pharmaceutical
11.7.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Company Information
11.7.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Overview
11.7.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments
11.8 Dalian Hissen Bio-pharm
11.8.1 Dalian Hissen Bio-pharm Company Information
11.8.2 Dalian Hissen Bio-pharm Overview
11.8.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Dalian Hissen Bio-pharm Recent Developments
11.9 Abbott Laboratories
11.9.1 Abbott Laboratories Company Information
11.9.2 Abbott Laboratories Overview
11.9.3 Abbott Laboratories Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Abbott Laboratories Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Abbott Laboratories Recent Developments
11.10 Novartis International AG
11.10.1 Novartis International AG Company Information
11.10.2 Novartis International AG Overview
11.10.3 Novartis International AG Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Novartis International AG Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novartis International AG Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Seasonal Influenza Vaccines Industry Chain Analysis
12.2 Seasonal Influenza Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Seasonal Influenza Vaccines Production Mode & Process
12.4 Seasonal Influenza Vaccines Sales and Marketing
12.4.1 Seasonal Influenza Vaccines Sales Channels
12.4.2 Seasonal Influenza Vaccines Distributors
12.5 Seasonal Influenza Vaccines Customers
13 Market Dynamics
13.1 Seasonal Influenza Vaccines Industry Trends
13.2 Seasonal Influenza Vaccines Market Drivers
13.3 Seasonal Influenza Vaccines Market Challenges
13.4 Seasonal Influenza Vaccines Market Restraints
14 Key Findings in The Global Seasonal Influenza Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Seasonal Influenza Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Type A (H1N1)
Table 3. Major Manufacturers of Type A (H3N2)
Table 4. Major Manufacturers of Type B
Table 5. Global Seasonal Influenza Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Seasonal Influenza Vaccines Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Seasonal Influenza Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global Seasonal Influenza Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2018-2023)
Table 10. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2024-2029)
Table 11. Global Seasonal Influenza Vaccines Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Seasonal Influenza Vaccines Sales by Region (2018-2023) & (K Units)
Table 13. Global Seasonal Influenza Vaccines Sales by Region (2024-2029) & (K Units)
Table 14. Global Seasonal Influenza Vaccines Sales Market Share by Region (2018-2023)
Table 15. Global Seasonal Influenza Vaccines Sales Market Share by Region (2024-2029)
Table 16. Global Seasonal Influenza Vaccines Sales by Manufacturers (2018-2023) & (K Units)
Table 17. Global Seasonal Influenza Vaccines Sales Share by Manufacturers (2018-2023)
Table 18. Global Seasonal Influenza Vaccines Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global Seasonal Influenza Vaccines Revenue Share by Manufacturers (2018-2023)
Table 20. Global Key Players of Seasonal Influenza Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
Table 21. Seasonal Influenza Vaccines Price by Manufacturers 2018-2023 (USD/Unit)
Table 22. Global Seasonal Influenza Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Seasonal Influenza Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Seasonal Influenza Vaccines as of 2022)
Table 24. Global Key Manufacturers of Seasonal Influenza Vaccines, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Seasonal Influenza Vaccines, Product Offered and Application
Table 26. Global Key Manufacturers of Seasonal Influenza Vaccines, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Seasonal Influenza Vaccines Sales by Type (2018-2023) & (K Units)
Table 29. Global Seasonal Influenza Vaccines Sales by Type (2024-2029) & (K Units)
Table 30. Global Seasonal Influenza Vaccines Sales Share by Type (2018-2023)
Table 31. Global Seasonal Influenza Vaccines Sales Share by Type (2024-2029)
Table 32. Global Seasonal Influenza Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global Seasonal Influenza Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Seasonal Influenza Vaccines Revenue Share by Type (2018-2023)
Table 35. Global Seasonal Influenza Vaccines Revenue Share by Type (2024-2029)
Table 36. Seasonal Influenza Vaccines Price by Type (2018-2023) & (USD/Unit)
Table 37. Global Seasonal Influenza Vaccines Price Forecast by Type (2024-2029) & (USD/Unit)
Table 38. Global Seasonal Influenza Vaccines Sales by Application (2018-2023) & (K Units)
Table 39. Global Seasonal Influenza Vaccines Sales by Application (2024-2029) & (K Units)
Table 40. Global Seasonal Influenza Vaccines Sales Share by Application (2018-2023)
Table 41. Global Seasonal Influenza Vaccines Sales Share by Application (2024-2029)
Table 42. Global Seasonal Influenza Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global Seasonal Influenza Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Seasonal Influenza Vaccines Revenue Share by Application (2018-2023)
Table 45. Global Seasonal Influenza Vaccines Revenue Share by Application (2024-2029)
Table 46. Seasonal Influenza Vaccines Price by Application (2018-2023) & (USD/Unit)
Table 47. Global Seasonal Influenza Vaccines Price Forecast by Application (2024-2029) & (USD/Unit)
Table 48. US & Canada Seasonal Influenza Vaccines Sales by Type (2018-2023) & (K Units)
Table 49. US & Canada Seasonal Influenza Vaccines Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Seasonal Influenza Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 51. US & Canada Seasonal Influenza Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Seasonal Influenza Vaccines Sales by Application (2018-2023) & (K Units)
Table 53. US & Canada Seasonal Influenza Vaccines Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Seasonal Influenza Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 55. US & Canada Seasonal Influenza Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Seasonal Influenza Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Seasonal Influenza Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 58. US & Canada Seasonal Influenza Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Seasonal Influenza Vaccines Sales by Country (2018-2023) & (K Units)
Table 60. US & Canada Seasonal Influenza Vaccines Sales by Country (2024-2029) & (K Units)
Table 61. Europe Seasonal Influenza Vaccines Sales by Type (2018-2023) & (K Units)
Table 62. Europe Seasonal Influenza Vaccines Sales by Type (2024-2029) & (K Units)
Table 63. Europe Seasonal Influenza Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 64. Europe Seasonal Influenza Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Seasonal Influenza Vaccines Sales by Application (2018-2023) & (K Units)
Table 66. Europe Seasonal Influenza Vaccines Sales by Application (2024-2029) & (K Units)
Table 67. Europe Seasonal Influenza Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 68. Europe Seasonal Influenza Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Seasonal Influenza Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Seasonal Influenza Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 71. Europe Seasonal Influenza Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Seasonal Influenza Vaccines Sales by Country (2018-2023) & (K Units)
Table 73. Europe Seasonal Influenza Vaccines Sales by Country (2024-2029) & (K Units)
Table 74. China Seasonal Influenza Vaccines Sales by Type (2018-2023) & (K Units)
Table 75. China Seasonal Influenza Vaccines Sales by Type (2024-2029) & (K Units)
Table 76. China Seasonal Influenza Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 77. China Seasonal Influenza Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Seasonal Influenza Vaccines Sales by Application (2018-2023) & (K Units)
Table 79. China Seasonal Influenza Vaccines Sales by Application (2024-2029) & (K Units)
Table 80. China Seasonal Influenza Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 81. China Seasonal Influenza Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Seasonal Influenza Vaccines Sales by Type (2018-2023) & (K Units)
Table 83. Asia Seasonal Influenza Vaccines Sales by Type (2024-2029) & (K Units)
Table 84. Asia Seasonal Influenza Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 85. Asia Seasonal Influenza Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Seasonal Influenza Vaccines Sales by Application (2018-2023) & (K Units)
Table 87. Asia Seasonal Influenza Vaccines Sales by Application (2024-2029) & (K Units)
Table 88. Asia Seasonal Influenza Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 89. Asia Seasonal Influenza Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Seasonal Influenza Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Seasonal Influenza Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 92. Asia Seasonal Influenza Vaccines Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Seasonal Influenza Vaccines Sales by Region (2018-2023) & (K Units)
Table 94. Asia Seasonal Influenza Vaccines Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales by Type (2018-2023) & (K Units)
Table 96. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Type (2018-2023) & (US$ Million)
Table 98. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales by Application (2018-2023) & (K Units)
Table 100. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Application (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America Seasonal Influenza Vaccines Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales by Country (2018-2023) & (K Units)
Table 107. Middle East, Africa and Latin America Seasonal Influenza Vaccines Sales by Country (2024-2029) & (K Units)
Table 108. GlaxoSmithKline plc Company Information
Table 109. GlaxoSmithKline plc Description and Major Businesses
Table 110. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 111. GlaxoSmithKline plc Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. GlaxoSmithKline plc Recent Developments
Table 113. Sinovac Biotech Ltd Company Information
Table 114. Sinovac Biotech Ltd Description and Major Businesses
Table 115. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 116. Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Sinovac Biotech Ltd Recent Developments
Table 118. Changsheng Bio-Technology Company Information
Table 119. Changsheng Bio-Technology Description and Major Businesses
Table 120. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 121. Changsheng Bio-Technology Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Changsheng Bio-Technology Recent Developments
Table 123. Ccbio SA Company Information
Table 124. Ccbio SA Description and Major Businesses
Table 125. Ccbio SA Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 126. Ccbio SA Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Ccbio SA Recent Developments
Table 128. Aleph Biomedical Company Information
Table 129. Aleph Biomedical Description and Major Businesses
Table 130. Aleph Biomedical Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 131. Aleph Biomedical Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Aleph Biomedical Recent Developments
Table 133. Sanofi Company Information
Table 134. Sanofi Description and Major Businesses
Table 135. Sanofi Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 136. Sanofi Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Sanofi Recent Developments
Table 138. Jiangsu Simcere Vaxtec Bio-pharmaceutical Company Information
Table 139. Jiangsu Simcere Vaxtec Bio-pharmaceutical Description and Major Businesses
Table 140. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 141. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments
Table 143. Dalian Hissen Bio-pharm Company Information
Table 144. Dalian Hissen Bio-pharm Description and Major Businesses
Table 145. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 146. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Dalian Hissen Bio-pharm Recent Developments
Table 148. Abbott Laboratories Company Information
Table 149. Abbott Laboratories Description and Major Businesses
Table 150. Abbott Laboratories Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 151. Abbott Laboratories Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Abbott Laboratories Recent Developments
Table 153. Novartis International AG Company Information
Table 154. Novartis International AG Description and Major Businesses
Table 155. Novartis International AG Seasonal Influenza Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 156. Novartis International AG Seasonal Influenza Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Novartis International AG Recent Developments
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Seasonal Influenza Vaccines Distributors List
Table 161. Seasonal Influenza Vaccines Customers List
Table 162. Seasonal Influenza Vaccines Market Trends
Table 163. Seasonal Influenza Vaccines Market Drivers
Table 164. Seasonal Influenza Vaccines Market Challenges
Table 165. Seasonal Influenza Vaccines Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Seasonal Influenza Vaccines Product Picture
Figure 2. Global Seasonal Influenza Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Seasonal Influenza Vaccines Market Share by Type in 2022 & 2029
Figure 4. Type A (H1N1) Product Picture
Figure 5. Type A (H3N2) Product Picture
Figure 6. Type B Product Picture
Figure 7. Global Seasonal Influenza Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Seasonal Influenza Vaccines Market Share by Application in 2022 & 2029
Figure 9. Pediatrics
Figure 10. Adolescence
Figure 11. Adults
Figure 12. Elderly
Figure 13. Seasonal Influenza Vaccines Report Years Considered
Figure 14. Global Seasonal Influenza Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Seasonal Influenza Vaccines Revenue 2018-2029 (US$ Million)
Figure 16. Global Seasonal Influenza Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2018-2029)
Figure 18. Global Seasonal Influenza Vaccines Sales 2018-2029 ((K Units)
Figure 19. Global Seasonal Influenza Vaccines Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Seasonal Influenza Vaccines Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Seasonal Influenza Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Seasonal Influenza Vaccines Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Seasonal Influenza Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Seasonal Influenza Vaccines Sales YoY (2018-2029) & (K Units)
Figure 25. China Seasonal Influenza Vaccines Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Seasonal Influenza Vaccines Sales YoY (2018-2029)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs